140 related articles for article (PubMed ID: 37778434)
1. Regional regulatory harmonisation initiatives: Their potential contribution to the newly established African Medicines Agency.
Ngum N; Ndomondo-Sigonda M; Walker S; Salek S
Regul Toxicol Pharmacol; 2023 Dec; 145():105497. PubMed ID: 37778434
[TBL] [Abstract][Full Text] [Related]
2. Establishment of the African Medicines Agency: progress, challenges and regulatory readiness.
Ncube BM; Dube A; Ward K
J Pharm Policy Pract; 2021 Mar; 14(1):29. PubMed ID: 33685518
[TBL] [Abstract][Full Text] [Related]
3. The process of ratifying the treaty to establish the African Medicines Agency: perspectives of national regulatory agencies.
Ncube BM; Dube A; Ward K
Health Policy Plan; 2024 May; 39(5):447-456. PubMed ID: 38497780
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Effectiveness and Efficiency of the East African Community Joint Assessment Procedure by Member Countries: The Way Forward.
Ngum N; Mashingia J; Ndomondo-Sigonda M; Walker S; Salek S
Front Pharmacol; 2022; 13():891506. PubMed ID: 35865962
[No Abstract] [Full Text] [Related]
5. What makes joint assessment procedures attractive to the innovative industry: successes, challenges, and proposed improvements.
Miletic N; Adam S; Acquah J; Aziz Z; Joos A; Mwangi JM
Front Med (Lausanne); 2023; 10():1207954. PubMed ID: 37731723
[TBL] [Abstract][Full Text] [Related]
6. Medicines Regulatory Science Expertise in Africa: Workforce Capacity Development and Harmonisation Activities Towards the Establishment of the African Medicines Agency.
Ncube BM; Dube A; Ward K
Pharmaceut Med; 2022 Apr; 36(2):83-97. PubMed ID: 35380413
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the effectiveness and efficiency of the East African community joint assessment procedure by pharmaceutical companies: Opportunities for improvement.
Ngum N; Mashingia J; Ndomondo-Sigonda M; Walker S; Salek S
Front Pharmacol; 2022; 13():1031289. PubMed ID: 36408267
[No Abstract] [Full Text] [Related]
8. Impact of regulatory requirements on medicine registration in African countries - perceptions and experiences of pharmaceutical companies in South Africa.
Narsai K; Williams A; Mantel-Teeuwisse AK
South Med Rev; 2012 Jul; 5(1):31-7. PubMed ID: 23093897
[TBL] [Abstract][Full Text] [Related]
9. Regulatory performance of the East African Community joint assessment procedure: The way forward for regulatory systems strengthening.
Mashingia J; Ngum N; Ndomondo-Sigonda M; Kermad A; Bujar M; Salek S; Walker S
Regul Toxicol Pharmacol; 2023 May; 140():105383. PubMed ID: 36933643
[TBL] [Abstract][Full Text] [Related]
10. The domestication of the African Union model law on medical products regulation: Perceived benefits, enabling factors, and challenges.
Ncube BM; Dube A; Ward K
Front Med (Lausanne); 2023; 10():1117439. PubMed ID: 36793874
[TBL] [Abstract][Full Text] [Related]
11. Industrial perceptions of medicines regulatory harmonization in the East African Community.
Dansie LS; Odoch WD; Ă…rdal C
PLoS One; 2019; 14(6):e0218617. PubMed ID: 31216323
[TBL] [Abstract][Full Text] [Related]
12. Outer packaging labelling of medicines in Southern African Development Community (SADC) countries: comparative analysis of requirements and transition terms for harmonisation.
Narsai K; Masekela FB; Leufkens HGM; Mantel-Teeuwisse AK
BMC Health Serv Res; 2024 Jan; 24(1):111. PubMed ID: 38245720
[TBL] [Abstract][Full Text] [Related]
13. Best practices in the African Medicines Regulatory Harmonization initiative: Perspectives of regulators and medicines manufacturers.
Ndomondo-Sigonda M; Azatyan S; Doerr P; Agaba C; Harper KN
PLOS Glob Public Health; 2023; 3(4):e0001651. PubMed ID: 37186241
[TBL] [Abstract][Full Text] [Related]
14. Advancing African Medicines Agency through Global Health Diplomacy for an Equitable Pan-African Universal Health Coverage: A Scoping Review.
Chattu VK; Dave VB; Reddy KS; Singh B; Sahiledengle B; Heyi DZ; Nattey C; Atlaw D; Jackson K; El-Khatib Z; Eltom AA
Int J Environ Res Public Health; 2021 Nov; 18(22):. PubMed ID: 34831511
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the effectiveness and efficiency of the economic community of West African States Medicines Regulatory Harmonization initiative by the pharmaceutical industry.
Owusu-Asante M; Darko DM; Walker S; Salek S
Front Pharmacol; 2023; 14():1184108. PubMed ID: 37229251
[No Abstract] [Full Text] [Related]
16. Strengthening regulatory capacity for gene drives in Africa: leveraging NEPAD's experience in establishing regulatory systems for medicines and GM crops in Africa.
Glover B; Akinbo O; Savadogo M; Timpo S; Lemgo G; Sinebo W; Akile S; Obukosia S; Ouedraogo J; Ndomondo-Sigonda M; Koch M; Makinde D; Ambali A
BMC Proc; 2018; 12(Suppl 8):11. PubMed ID: 30079102
[TBL] [Abstract][Full Text] [Related]
17. Harmonization of medical products regulation: a key factor for improving regulatory capacity in the East African Community.
Ndomondo-Sigonda M; Miot J; Naidoo S; Masota NE; Ng'andu B; Ngum N; Kaale E
BMC Public Health; 2021 Jan; 21(1):187. PubMed ID: 33478421
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the effectiveness and efficiency of the West Africa medicines regulatory harmonization initiative by the member countries.
Owusu-Asante M; Darko DM; Walker S; Salek S
Front Pharmacol; 2022; 13():1069345. PubMed ID: 36506579
[No Abstract] [Full Text] [Related]
19. Regulation of medical diagnostics and medical devices in the East African community partner states.
Rugera SP; McNerney R; Poon AK; Akimana G; Mariki RF; Kajumbula H; Kamau E; Mpawenimana S; Said SY; Toroitich A; Ronoh W; Sollis KA; Sonoiya S; Peeling RW
BMC Health Serv Res; 2014 Oct; 14():524. PubMed ID: 25366990
[TBL] [Abstract][Full Text] [Related]
20. Medicines Regulation in Africa: Current State and Opportunities.
Ndomondo-Sigonda M; Miot J; Naidoo S; Dodoo A; Kaale E
Pharmaceut Med; 2017; 31(6):383-397. PubMed ID: 29200865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]